Balance Sheet
Cash Flow Statement
AmortizationAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Taxes (2020)

Historic Change in Taxes for Legend Biotech (LEGN) over the last 3 years, with Q4 2022 value amounting to $3.7 million.

  • Legend Biotech's Change in Taxes rose 56588.87% to $3.7 million in Q4 2022 from the same period last year, while for Sep 2023 it was $4.3 million, marking a year-over-year decrease of 4632.61%. This contributed to the annual value of $3.7 million for FY2022, which is 56588.87% up from last year.
  • Latest data reveals that Legend Biotech reported Change in Taxes of $3.7 million as of Q4 2022, which was up 56588.87% from $557000.0 recorded in Q4 2021.
  • Over the past 5 years, Legend Biotech's Change in Taxes peaked at $7.4 million during Q4 2020, and registered a low of $508000.0 during Q3 2020.
  • In the last 3 years, Legend Biotech's Change in Taxes had a median value of $3.7 million in 2020 and averaged $3.2 million.
  • Its Change in Taxes has fluctuated over the past 5 years, first tumbled by 9246.38% in 2021, then soared by 56588.87% in 2022.
  • Over the past 3 years, Legend Biotech's Change in Taxes (Quarter) stood at $7.4 million in 2020, then crashed by 92.46% to $557000.0 in 2021, then soared by 565.89% to $3.7 million in 2022.
  • Its Change in Taxes stands at $3.7 million for Q4 2022, versus $557000.0 for Q4 2021 and $7.4 million for Q4 2020.